Pluriomics' Series A Round

Pluriomics raised a round of funding on October 16, 2014.

Pluriomics is a Belgian/Dutch biotechnology company whose mission is to deliver cardiac drug discovery and safety solutions based on its best-in-class human iPSC-derived cardiomyocyte technology. Spec…

Articles about Pluriomics' Series A Round: